ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt/β-catenin regulatory axis in colorectal cancer

Li, Shi-ying; Shi, Chuan-jian; Fu, Wei-ming; Zhang, Jin-fang*广州中医药大学; 南方医科大学
Journal of Pharmacy and Pharmacology2023-1-31DOI: 10.1093/jpp/rgac067
3被引6阅读
引用收藏
分享

摘要

Background Berberine, a non-prescription medicine clinically applied for diarrhoea and gastroenteritis. Recent studies have demonstrated that it possesses anti-tumour properties in colorectal cancer, but the exact molecular mechanism remains obscure. @@@ Objectives To elucidate the underly molecular mechanisms of berberine in colorectal cancer from a perspective of epigenetics, and tried to explore the role of lincROR-Wnt/beta-catenin molecular axis in the berberine induced the anti-tumour activity in colorectal cancer. @@@ Methods The effects of berberine on cell growth, cell cycle and apoptosis were examined in CRC cells. The in vivo effect of berberine on tumour growth was investigated using a xenograft mice model. Moreover, lincROR and Wnt/beta-catenin signalling were detected by luciferase activity, qRT-PCR and western blotting assays. @@@ Key findings Berberine suppressed cell growth in vitro via inducing cell cycle arrest and apoptosis in CRC cell, and inhibited tumourigenesis in vivo. LincROR was significantly down-regulated by berberine, inducing the inactivation of the canonical Wnt/beta-catenin signalling, meanwhile, the overexpression of lincROR partially reversed the suppressive effects on tumour growth and Wnt/beta-catenin signalling induced by berberine. @@@ Conclusions Berberine inhibits tumour growth partially via regulating the lincROR-Wnt/beta-catenin regulatory axis, which provides a strategy for the design of anti-tumour drugs for CRC patients after our advanced validation.

学科与关键词

关键词
berberinelincRORWnt/beta-catenin signallingHT29 and SW620xenograft model
相关
加载中…
  • Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer
    He, Xiangli; Cui, Jiayan; Ma, Hui; Abuduaini, Naijipu; Huang, Ying; Tang, Lu; Wang, Wanyan; Zhang, Yuanyuan; Wang, Yang; Lu, Weiqiang*; Feng, Bo*; Huang, Jin*Biochemical Pharmacology, 2023, 218: 115868.
  • Icariside II suppressed tumorigenesis by epigenetically regulating the circβ-catenin-Wnt/β-catenin axis in colorectal cancer
    Shi, Chuan-Jian; Li, Shi-Ying; Shen, Chun-Hui; Pan, Fei-Fei; Deng, Li-Qiang; Fu, Wei-Ming*; Wang, Ji-Yong*; Zhang, Jin-Fang*Bioorganic Chemistry, 2022, 124: 105800.被引 2
  • Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma
    Lin, Xian; Chen, Jian; Li, Xin; Chen, Dong; Luo, Kaixuan; Deng, Yongxing; Yang, Dinghua*; Huang, Zunnan*; Tao, Cheng*Archives of Toxicology, 2023, 97(6): 1627-1647.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Pharmacy and Pharmacology
发表日期
2023-01-31
卷期
第 75 卷, 第 1 期
页码
129-138
DOI
10.1093/jpp/rgac067
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773066, 81772404]; Natural Science Foundation of Guangdong Province [2020A151501096120, 21A1515012111]

作者

  • L

    Li, Shi-ying (第一作者)

    southern med univ

  • S

    Shi, Chuan-jian

    southern med univ

查看全部 4 位作者收起作者
  • F

    Fu, Wei-ming

    southern med univ

  • Z

    Zhang, Jin-fang (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417